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Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the
English Cancer Patient Experience Survey
Prolonged diagnostic intervals may negatively affect the patient experience of subsequent cancer care, but
evidence about this assertion is sparse. We analysed data from 73 462 respondents to two English Cancer
Patient Experience Surveys to examine whether patients with three or more (3+) pre-referral consultations
were more likely to report negative experiences of subsequent care compared with patients with one or two
consultations in respect of 12 a priori selected survey questions. For each of 12 experience items, logistic
regression models were used, adjusting for prior consultation category, cancer site, socio-demographic case-
mix and response tendency (to capture potential variation in critical response tendencies between
individuals). There was strong evidence (P < 0.01 for all) that patients with 3+ pre-referral consultations
reported worse care experience for 10/12 questions, with adjusted odds ratios compared with patients with
1–2 consultations ranging from 1.10 (95% confidence intervals 1.03–1.17) to 1.68 (1.60–1.77), or between
+1.8% and +10.6% greater percentage reporting a negative experience. Associations were stronger for
processes involving primary as opposed to hospital care; and for evaluation than report items. Considering
1, 2, 3–4 and ‘5+’ pre-referral consultations separately a ‘dose–response’ relationship was apparent. We
conclude that there is a negative association between multiple pre-diagnostic consultations with a general
practitioner and the experience of subsequent cancer care.
Keywords: cancer, oncology, patient experience, referral, general practitioner, consultation.
BACKGROUND
Most cancer patients are diagnosed after the onset of
symptoms caused by their cancer, typically after present-
ing to a general practitioner (GP; Elliss-Brookes et al.
2012). Although most such patients are referred promptly
for specialist assessment, some experience multiple con-
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sultations which lead to prolonged intervals to specialist
referral (Lyratzopoulos et al. 2012, 2013). Policy initia-
tives in several countries aim to shorten intervals from
presentation to diagnosis (Department of Health, 2001;
Olesen et al. 2009; Prades et al. 2011). Several considera-
tions motivate such policies, including improving clinical
outcomes and minimising the frequency of medico-legal
complaints (Torring et al. 2012; Wallace et al. 2013). Fur-
thermore, patients express a strong preference for prompt
diagnostic assessment after presentation, and most would
opt for investigation for possible cancer at risk levels as
low as 1% (Pancreatic Cancer UK, 2011; Rarer Cancer
Foundation, 2011; The Roy Castle Lung Cancer Founda-
tion, 2011; Banks et al. 2014). It is therefore plausible that
prolonged diagnostic intervals after presentation could be
perceived by patients as indicative of sub-optimal care
early on in their journey, and negatively colour their expe-
rience of subsequent care. In the commercial sector, there
is growing recognition of the enduring effects of the first
encounter on subsequent service experience. Concor-
dantly, surveys of cancer patients in the Netherlands and
Denmark indicate that ‘rapid and adequate referral’ is one
of the five most important aspects of care quality; and that
delayed referral is associated with greater chance of
decreased confidence in a patient’s GP respectively (Lar-
sen et al. 2011; Booij et al. 2013). Prior evidence also indi-
cates that rapid diagnostic pathways may be associated
with reduced patient anxiety (Brocken et al. 2014). Other
evidence about the potential influence of diagnostic delays
on the experience of subsequent cancer care is limited to
case-series with small sample sizes or is anecdotal (Ris-
berg et al. 1996; Gallagher et al. 2010; Tomlinson et al.
2012). Indeed, a recent systematic review on the associa-
tion between diagnostic timeliness and cancer outcomes
lamented the lack of evidence of the impact of delays on
patient-reported outcomes and indicated ‘a dearth of stud-
ies reporting patient experience’ (Neal et al. 2015).
In recent years, large national surveys of cancer patients
have been carried out in England (Cancer Patient Experi-
ence Survey, CPES). These include questions about the
experience of several aspects of cancer care, including
diagnostic testing, shared decision-making, nurse commu-
nication, doctor communication, care coordination and
overall satisfaction with cancer care. At the start of the
questionnaire, respondents are also asked to indicate
whether their diagnosis involved prior consultations with
a GP, and if so, the number of such consultations. Against
this background, we examined associations between the
number of pre-diagnostic GP consultations before referral
for specialist assessment and the evaluation of subsequent
cancer care.
METHODS
Data
Source
We used anonymous data from respondents to the English
CPESs 2011/2012 and 2012/2013 (hereafter referred to as
‘2012’ and 2013’ surveys; Department of Health, 2012a,
2013). Both surveys were commissioned by the UK
Department of Health and carried out by Quality Health
(Chesterfield, UK), a specialist survey provider (Depart-
ment of Health, 2012b; Quality Health, 2013). Items were
cognitively tested in panels of volunteer patients, facili-
tated by a national cancer charity. The survey’s sampling
frame includes all patients treated in English National
Health Service (NHS) hospitals for cancer during a 3-
month period (September to November 2011 and 2012,
respectively for the 2012 and the 2013 surveys). After vital
status checks, patients were mailed the survey question-
naire, with up to two reminders for non-responders.
Response rates were 68% and 64% for the 2012 and the
2013 surveys (Department of Health, 2012b; Quality
Health, 2013). Anonymous data from the surveys are
available for research purposes from the UK Data Archive
(http://www.data-archive.ac.uk/), as used in the present
study (Department of Health, 2012a, 2013).
Sample derivation
For both surveys, information was available on patients’
age, sex and International Classification of Diseases-10
diagnosis code (based on hospital records); and self-as-
signed ethnic group, using the Office of National Statistics
6-category classification (based on responses to a survey
item) (Saunders et al. 2013). We a priori restricted the
analysis to patients who, in response to a survey item, had
indicated that their cancer was diagnosed in the last year,
to minimise potentially ‘double-counting’ some respon-
dents to the 2013 survey who might have also been sam-
pled and responded to the 2012 survey. We also restricted
the analysis to patients with any of 24 cancer diagnosis
groups for which promptness of referral was previously
described (Lyratzopoulos et al. 2012). We excluded from
further analysis respondents with missing or non-informa-
tive answers (‘don’t know/can’t say’) to questions 1 (on
promptness of referral after presentation, the main expo-
sure of prior interest, see below) and 70 (on overall care
satisfaction with care, used in sensitivity analysis as
explained below), and those with missing self-assigned
ethnicity, leaving 73,462 respondents for subsequent
analyses (Appendix 1).
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Analysis
Main exposure variable
We used information from the survey question 1 ‘Before
you were told you needed to go to hospital about cancer,
howmany times did you see your GP (family doctor) about
the health problem caused by cancer?’, with possible infor-
mative answers ‘None – I did not see my GP before going
to hospital’, ‘once’, ‘twice’, ‘three or four times’ and ‘five
or more times’. For the main analysis, three categories of
pre-referral consultations with a GP before hospital refer-
ral were defined: 1 or 2 (‘1–2’); 3 or more (‘3+’); and no prior
GP consultations.
Outcome variables
A group of 12 survey questions (items) was selected a
priori to reflect different aspects of the cancer pathway
across nine domains of care experience (Box 1). These
included eight evaluative items (e.g. assessing the qual-
ity of inter-personal care skills of nurses or doctors)
and four items where patients reported on actual pro-
cesses of care, such as whether they had access to a
specialist nurse. These we termed report-type items
and, a priori, we did not expect associations with pre-
referral consultations. Of the 12 questions, three had
binary response options and nine used a Likert
response format. However, as public reporting conven-
tions for the CPES use binary categories (positive/nega-
tive experience of care) for all questions, these binary
forms were used in our analysis. Except for a single
question (on length of waiting time to be seen as an
outpatient) which was only included in one of the two
surveys, all other 11 questions were (identically)
included in both surveys – for ease of reference ques-
tion numbers relate to the 2013 survey except if other-
wise noted. The exact form of each question is
provided in Box 1.
Box 1 . Exact wording of questions on aspects of care experience of cancer patients (question numbers correspond
to the 2013 survey)
Questions (number, stem, questionnaire domain)
Evaluation items
12. How do you feel about the way you were told you had cancer?
Within domain entitled ‘Finding out what was wrong with you’
20. Were you involved as much as you wanted to be in decisions about your care and treatment?
Within domain ‘Deciding the best treatment for you’
38. Did you have confidence and trust in the doctors treating you?
Within domain ‘Hospital Doctors’
42. Did you have confidence and trust in the ward nurses treating you?
Within domain ‘Ward Nurses’
45. While you were in hospital did you ever think that the doctors or nurses were deliberately not telling you certain things
that you wanted to know?
Within domain ‘Hospital care and treatment’
64. Do you think the GPs and nurses at your general practice did everything they could to support you while you were having
cancer treatment?
Within domain ‘Care from your General Practice’
65. Did the different people treating and caring for you (such as GP, hospital doctors, hospital nurses, specialist nurses,
community nurses) work well together to give you the best possible care?
Within domain ‘Your overall NHS care’
70. Overall, how would you rate your care?
Within domain ‘Your overall NHS care’
Report items
21. Were you given the name of a Clinical Nurse Specialist who would be in charge of your care?
Within section entitled ‘Clinical Nurse Specialist’
53. Were you given clear written information about what you should or should not do after leaving hospital?
Within domain ‘Hospital care and treatment’
61. (2012 survey). The last time you had an outpatients appointment with a cancer doctor at one of the hospitals named in the
covering letter, how long after the stated appointment time did the appointment start?
Within domain ‘Outpatient appointments with doctors’
63. As far as you know, was your GP given enough information about your condition and the treatment you had at the
hospital?
Within domain ‘Care from your General Practice’
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Statistical analysis
For each of the 12 questions in turn, we used logistic
regression models to examine associations between
promptness of referral and subsequent care experience.
After first describing crude proportions, we considered
three separate models for each question, first estimating
the crude (unadjusted) odds of negative experience; then
the odds of negative experience adjusted for patient char-
acteristics (age, sex and ethnicity) and cancer diagnosis;
and lastly, the odds of negative experience adjusted for the
overall response tendency of each individual patient, addi-
tionally to patient characteristics and cancer diagnosis.
Response tendency is a construct often considered in
patient-reported outcome measures. It aims to capture
potential variation in critical response tendencies between
individuals. Adjusting for response tendency minimises
the potential for apparent associations to be driven by
common biases in the measurement of both the outcome
(i.e. care experience) and exposure (i.e. number of consul-
tations) variables by participants who provide answers
that are systematically more or less critical than the aver-
age respondent. To create a measure of response tendency
for each patient, we adjusted their responses to each indi-
vidual question for their answers to up to nine other ques-
tions as detailed in Appendix 2. Essentially, this approach
adjusts the reported experience for clustering of more or
less critical responses among individual respondents.
Supplementary analysis
In supplementary analysis, we examined the presence of a
‘dose–response’ relationship (i.e. whether greater number
of consultations was associated with less positive experi-
ence). We did this by considering all four ordinal categories
of pre-referral consultations included as possible responses
in the relevant survey item separately (i.e. ‘once’, ‘twice’,
‘three or four times’, and ‘five or more times’).
Sensitivity analysis
We repeated the main analysis model additionally adjust-
ing for patient socioeconomic status, based on the Index of
Multiple Deprivation 2007 scores of the lower super out-
put area of patients’ residence (only available for 2013 sur-
vey respondents) (Indices of Deprivation, 2007). In
addition, for each of the 11 questions other than overall
satisfaction (question 70), we repeated the logistic regres-
sion model by substituting the measure of response ten-
dency described above with the patient’s overall
satisfaction with their care.
RESULTS
Sample description
Among 73 462 patients included in the initial analysis
sample, 44 827 (61.0%) had seen their GP once or twice
before referral and 13 280 (18.1%) had seen the GP three
or more times, while in 15 355 (20.9%) patients, the
diagnostic process did not involve prior consultation
with a GP. Among patients whose diagnosis involved at
least one primary care consultation, 77.1% had seen
their GP once or twice, and 22.9% three or more times.
The number of patients with valid responses to each of
the 12 outcome questions ranged from 32 999 (for ques-
tion 61, regarding length of waiting time in the outpa-
tient department; a question only included in the 2013
survey) to 73 452 (for question 70, overall satisfaction
with cancer care). The variability in the number of
respondents by question chiefly reflects the fact that
some questions do not apply to all patients (e.g. the
question on confidence and trust towards ward nurses
would only apply to patients who had an inpatient stay
during the sampling period). Crude proportions of
patients reporting a negative experience varied substan-
tially between questions, from 5.3% of patients report-
ing that their GP was not given enough information
about their treatment plan (question 63) to 34.5% of
patients indicating sub-optimal coordination of their
care (question 65). The analysis sample comprised
patients with 24 different diagnosis of cancer, the three
most common cancers being breast (18 787, 26%), colon
(7357, 10%) and prostate (6180, 8%) whilst the three
most rarer were laryngeal (521, 0.7%), testicular (441,
0.6%) and vulval (248, 0.3%), Appendix 3.
Consultations and subsequent care experience
Patients with three or more consultations were more
likely (P < 0.001) to report a negative experience than
patients with only one or two consultations for all 12
questions, with odds ratios ranging from 1.17 to 1.91
(Tables 1 and 2).
After adjusting for age, sex, ethnicity and cancer diagno-
sis, there was strong evidence (P < 0.01 for all) that
reported negative experience was more common among
patients with three or more consultations compared with
those who had just one or two consultations across all 12
questions (Table 2). There was a degree of attenuation of
effect sizes (i.e. adjusted odds ratio values being lower
compared with unadjusted odds ratio ones), indicating
that crude associations were partially confounded by
patient characteristics and cancer diagnosis.
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After additionally adjusting for response tendency, there
was still evidence that patients with three or more pre-re-
ferral consultations were more likely to report negative
experience for 10 of the 12 questions (P ≤ 0.007), with a
degree of further attenuation of effect sizes (Table 2;
Fig. 1).
Generally, observed associations tended to be stronger
for the evaluative-type questions which reflected aspects
of management that at least partially involve primary
care, e.g. the degree of support provided to cancer patients
by staff in their general practice (question 64), and the
experience of integration between hospital and primary
care (question 65). In contrast, for report-type questions
solely relating to within-hospital care processes (e.g. out-
patient’s waiting time, or access to specialist nursing,
questions 61 and 21 respectively) associations were weak
(Tables 1 and 2; Fig. 1).
To further illustrate the findings, we used the outputs of
the fully adjusted (i.e. for patient case-mix and response
tendency) regression models used in the main analyses to
calculate the predicted percentage of patients reporting
negative experiences should all patients had been in each of
the different categories of number of consultations. Com-
pared with patients with 1–2 consultations, those with 3+
consultations had between +1.8% and +10.6% greater
absolute proportions of negative experience, for the 10
questions with a significant association (Table 1).
Supplementary and sensitivity analyses
Considering each ordinal category of the number of pre-re-
ferral consultations separately, a strong ‘dose–response’
monotonic pattern was apparent, with greater number of
consultations consistently associated with greater chance
of reported negative evaluation of experience (Fig. 2,
Appendix 4). Adjustment for socioeconomic status (2013
survey sample only) produced findings that were concor-
Table 2. Odds ratios (and related 95% confidence intervals and P-values) for negative experience between patients with ‘three or more
consultations’ with a general practitioner compared with ‘one or two consultations’ (used as the reference category)
Question (number
and synoptic form) N
Unadjusted (crude) odds
ratios
Odds ratios adjusted for
patient case-mix (i.e. age,
sex, ethnicity and cancer
diagnosis)
Odds ratios adjusted for
patient case-mix and
measure of response
tendency
Odds
ratio
95%
confidence
interval P
Odds
ratio
95%
confidence
interval P
Odds
ratio
95%
confidence
interval P
Evaluation items
Q64 Practice staff support 49 158 1.86 1.77–1.95 <0.001 1.84 1.75–1.93 <0.001 1.68 1.60–1.77 <0.001
Q65 Cancer care integration 70 003 1.74 1.67–1.81 <0.001 1.67 1.60–1.74 <0.001 1.48 1.41–1.55 <0.001
Q70 Overall care satisfaction 73 452 1.91 1.81–2.02 <0.001 1.77 1.67–1.88 <0.001 1.44 1.35–1.54 <0.001
Q12 Told diagnosis sensitively 72 621 1.75 1.66–1.84 <0.001 1.53 1.46–1.62 <0.001 1.38 1.31–1.46 <0.001
Q45 Thought
information withheld
55 294 1.82 1.71–1.95 <0.001 1.53 1.42–1.63 <0.001 1.27 1.18–1.37 <0.001
Q42 Confidence and
trust – ward nurse
55 229 1.51 1.44–1.59 <0.001 1.40 1.33–1.47 <0.001 1.22 1.15–1.29 <0.001
Q38 Confidence and
trust – hospital doctor
55 494 1.69 1.59–1.79 <0.001 1.52 1.42–1.62 <0.001 1.22 1.13–1.31 <0.001
Q20 Shared decision-making 70 269 1.40 1.34–1.46 <0.001 1.32 1.26–1.38 <0.001 1.13 1.08–1.19 <0.001
Report items
Q63 Information given to GP 59 073 1.85 1.70–2.02 <0.001 1.64 1.50–1.79 <0.001 1.36 1.24–1.50 <0.001
Q61 Outpatient waiting time 32 999 1.17 1.10–1.25 <0.001 1.17 1.10–1.25 <0.001 1.10 1.03–1.17 0.007
Q53 Written info post-discharge 52 355 1.55 1.46–1.65 <0.001 1.27 1.20–1.36 <0.001 1.06 0.99–1.13 0.100
Q21 Given name of Clinical
Nurse Specialist (CNS)
69 793 1.18 1.10–1.26 <0.001 1.10 1.03–1.18 0.006 1.00 0.93–1.07 0.894
Questions are ordered by effect size for response tendency model within evaluation and report categories.
Figure 1. Odds ratios (and 95% CIs) for negative experience for
patients with ‘three or more’ pre-referral consultations with a
general practitioner, compared with patients with 1–2 consulta-
tions (reference). Questions ordered by effect size with evalua-
tive questions on the left and report questions on the right. CI,
confidence interval.
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dant with those observed in the main analysis. Adjusting
for overall satisfaction with care (question 70) as an alter-
native measure of response tendency produced similar
findings with those observed in the main analysis, uni-
formly for the 11 questions where this analysis was appli-
cable, with odds ratio values between those obtained by
the main analysis (adjusted for both patient case-mix and
a measure of response tendency) and those adjusted for
patient case-mix alone (Appendix 5).
DISCUSSION
The findings indicate that patients with cancer are more
likely to report worse care experience if they had a greater
number of pre-diagnosis consultations with a GP before
they were referred for specialist assessment. These associ-
ations are particularly apparent for evaluation (as opposed
to report) items that at least partially reflect aspects of
post-diagnosis management that involve primary care
staff. The findings were robust to sensitivity analyses
adjusting for patient deprivation status and different
approaches to measuring response tendency, and showed a
clear ‘dose–response’ pattern.
Findings in relation to other evidence
Prior evidence about the impact of promptness of investi-
gation after symptomatic presentation on care experience
comes from smaller surveys restricted to a much narrower
spectrum of aspects of care experience (Risberg et al.
1996; Larsen et al. 2011; Tomlinson et al. 2012; Booij
et al. 2013). A number of cancer charities have in recent
years advocated that delays in suspecting cancer in pri-
mary care may have a negative impact on care experience
for patients and their loved ones (Pancreatic Cancer UK,
2011; Rarer Cancer Foundation, 2011; The Roy Castle
Lung Cancer Foundation, 2011). In addition, patients
express strong preferences for timely investigation for sus-
pected cancer (Banks et al. 2014). The findings therefore
substantially augment the present state of evidence, and
at least partially address a recent call by authors of a sys-
tematic review for more evidence on the association
between timeliness of diagnosis and patient-reported out-
comemeasures (Neal et al. 2015).
To further contextualise the findings, it is useful to indi-
rectly compare the size of observed differences to that of
other, previously, described variations in the experience of
cancer care, e.g. variations by age group or cancer site. In
that respect, the odds of negative experience for patients
with 3+ consultations for question 64 (on practice staff
support, i.e. the item with the largest noted difference and
an adjusted odds ratio value of 1.68) is of similar magni-
tude to differences in patient experience for the same item
between 25–34 and 65–74 year olds, or between patients
with renal and rectal cancer (Saunders et al. 2015). These
comparisons indicate that overall the differences cannot
be dismissed as ignorable, especially if we consider that
this binary categorisation (three or more vs. one or two
consultations) hide larger differences between extreme
categories (i.e. 5+ consultations vs. 1 consultation – see
Appendix 4).
Strengths and limitations
The study strengths include its large nationwide sample,
and the inclusion of patients diagnosed in a recent period.
Furthermore, we were able to adjust the analyses for socio-
demographic characteristics and cancer diagnosis, vari-
ables known to be associated with both promptness of spe-
cialist referral and the evaluation of care experience
(Lyratzopoulos et al. 2012, 2013; Saunders et al. 2015). In
addition, we have been able to adjust the findings for
potential bias from differential response tendency. The
survey also had a relatively high (for a postal questionnaire
survey) response rate, with about two-thirds of eligible
patients responding. For comparisons, the large Hospital
Consumer Assessment and Healthcare Providers and Sys-
tems survey of US patients has a response rate of <40%, as
does the English General Practice Patient Survey (Jha
et al. 2008; Roland et al. 2009). Furthermore, the fact that
estimates of associations were case-mix adjusted min-
imises concerns about potential bias measurement of
these associations (Groves & Peytcheva 2008).
Figure 2. Supplementary analysis considering the odds of nega-
tive experience, by number of pre-referral consultations (‘one’
pre-referral consultation used as the reference category). Note
overall clear ‘dose–response’ relationship for questions where
evidence of association is present (see Table 2 and main text).
Questions ordered as in Figure 1.
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Another limitation is that by the nature of the study we
were not able to examine the potential influence of a range
of variables, which may confound or/and mediate the
observed association. For example, considering potential
confounding, cancer patients with a higher level of co-
morbidity may both report more critical experiences (be-
cause of greater care needs) and be at higher risk of multi-
ple pre-referral consultations (if symptoms caused by their
cancer are wrongly attributed to their pre-existing condi-
tions). In addition, some patients may have personality
traits which may impede the effectiveness of communica-
tion with a doctor during a consultation and at the same
time be associated with a tendency to respond to experi-
ence questions more critically. Furthermore, considering
potential mediators, for patients who present with organ-
confined tumours, untimely referral may increase the risk
progression to a more advanced stage, which is in turn
associated with worse experience of care (Ayanian et al.
2010). We do not, however, believe this is likely to be a
mechanism affecting more than very few patients in our
sample, given the fact that, on average, delays associated
with greater number of consultations are relatively pretty
short on average (i.e. an approximate median of 1 and
1.5 months for patients who experience three or four pre-
referral consultations) (Lyratzopoulos et al. 2013). Criti-
cally, the above limitations need to be interpreted in the
light of the fact that observed associations are more pro-
nounced for aspects of management that involve primary
care, and tend to be concentrated on evaluative as opposed
to report items. These observations indicate that where
present, associations between promptness of referral and
subsequent care experience cannot be fully explained by
potential either residual confounding or the mediating
effects of disease progression.
We were not able to directly measure the impact of
additional number of pre-referral consultations on the
overall length of the primary care interval (i.e. the
number of days from presentation to referral) (Weller
et al. 2012). However, national audit evidence indicates
that the number of pre-referral consultations is strongly
associated with the length of the primary care interval
(Spearman’s rank correlation coefficient r = 0.70) (Lyrat-
zopoulos et al. 2013). Specifically, while the median
primary care interval for patients with a single consul-
tation is 0 days, it is 34, 47 and 96 days for patients
with three, four and five or more consultations respec-
tively (Lyratzopoulos et al. 2013). Therefore, the mea-
sure used in this study (number of consultations) has
construct validity as a marker of the length of the pri-
mary care interval. We had no information on symp-
toms at presentation, and we were therefore unable to
examine potential variation in the observed associa-
tions by symptom type and/or adjust for symptom sta-
tus. Further, associations between untimely referral
and subsequent experience may differ between patients
with different presenting symptoms, a question for
future research.
Interpretation and implications
The findings indicate that multiple pre-referral consulta-
tions with a GP seem to ‘prime’ patients for a less positive
evaluation of the experience of subsequent care. There-
fore, they provide an additional supportive argument for
policy initiatives and ongoing research aimed at reducing
diagnostic delays after symptomatic presentations in pri-
mary care. These initiatives may include diagnostic test
development and greater use of existing tests; decision-
making support during the primary care consultation; and
system-wide engineering approaches (such as enabling
greater access to specialist advice and investigations)
(Lyratzopoulos et al. 2014).
Furthermore, the fact that untimely diagnosis may
affect the experience of post-diagnosis cancer manage-
ment in primary care has implications for survivorship
care, given the increasing development of care models
embedded in general practice (Emery 2014).
Future research should aim to examine whether co-
morbidity and stage at diagnosis confound or mediate
the observed association between promptness of referral
and subsequent experience. Such analysis can be ide-
ally supported by examining patient survey and clinical
outcomes considered together. Future studies should
also assess the potential impact of less prompt referral
on the quality of life of cancer patients and the psy-
chological mechanisms by which it affects subsequent
experience (Robinson et al. 2012). Qualitative studies
of cancer patients with prompt and untimely referral
history would be highly valuable.
We should lastly state that, in itself, the number of pre-
referral consultations is a measure of experience. There-
fore, it cannot be argued that number of consultations
would have not mattered for patient experience had null
associations between number of pre-referral consultations
and subsequent aspects of experience been observed.
In conclusion, we have provided large scale evidence
from a real-world setting suggesting that less prompt refer-
ral for specialist assessment after symptomatic presenta-
tion negatively affect the experience of subsequent cancer
care. These realisations support efforts to increase the
proportion of cancer patients who experience a prompt
referral.
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APPENDIX 2
Calculation of response tendency measure
For this analysis, the data were set in a ‘long’ format. In
such a dataset, each patient has a separate record for the
response to each question (i.e. multiple records per patient).
We estimated response tendency by running mixed effect
models predicting the odds of negative experience across all
questions, adjusting for question number with a fixed
effect, and with a random intercept for patient. The fixed
effect for question number accounts for the fact that some
questions are more likely than others to be answered posi-
tively by all patients and the random effect for patient
accounts for the fact that responses to multiple questions
are clustered within patients and that some patients are
more likely to give negative responses (regardless of ques-
tion number) than others. This random effect can be consid-
ered to capture a latent variable which is the patients
underlying response tendency. To obtain an estimate of this
latent variable for each patient we calculate the best linear
unbiased predictor for the random effect, and used this as
our response tendency variable in the main analysis.
We obtained nine different versions of this latent vari-
able, depending on the outcome question of the multino-
mial model. In all models, we excluded from adjustment
answers to the three questions that related to processes of
care which may have involved primary care staff (because
of potential for an intrinsic association between primary
care experience and primary care diagnosis); and the ques-
tion about overall satisfaction with cancer care (both
because satisfaction may be influenced by primary care
processes, and because it is a possible marker of response
tendency in itself). For these four questions we used a
common latent variable. For the remaining eight outcome
questions we excluded adjusting for that question from
the random effect model. The following table indicates
the adjustments made for each outcome question.
Outcome in main analysis model
Questions excluded
from random effect model
12 Told diagnosis sensitively 12 and 63, 64, 65, 70
20 Shared decision-making 20 and 63, 64, 65, 70
21 Given name of clinical nurse
specialist (CNS)
21 and 63, 64, 65, 70
38 Confidence and trust in doctors 38 and 63, 64, 65, 70
42 Confidence and trust in ward nurses 42 and 63, 64, 65, 70
45 Thought information withheld from them 45 and 63, 64, 65, 70
53 Written information at discharge 53 and 63, 64, 65, 70
61 Outpatient appointment waiting time 61 and 63, 64, 65, 70
63 Information given to GP (by hospital) 63, 64, 65, 70
64 General practice staff support 63, 64, 65, 70
65 Cancer care integration 63, 64, 65, 70
70 Overall care satisfaction 63, 64, 65, 70
APPENDIX 3
Sample composition in terms of cancer diagnosis
N %
Breast 18 787 25.6
Colon 7357 10
Prostate 6180 8.4
Lung 5589 7.6
Bladder 5532 7.5
Rectal 4801 6.5
Non-Hodgkin lymphoma 4445 6.1
Melanoma 2558 3.5
Endometrial 2402 3.3
Oesophageal 2173 3
Ovarian 2077 2.8
Multiple myeloma 1812 2.5
Leukaemia 1743 2.4
Stomach 1460 2
Renal 1276 1.7
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Table . Continued
N %
Pancreatic 906 1.2
Hodgkin’s lymphoma 689 0.9
Thyroid 686 0.9
Cervical 664 0.9
Brain 569 0.8
Mesothelioma 546 0.7
Laryngeal 521 0.7
Testicular 441 0.6
Vulval 248 0.3
APPENDIX 4
Supplementary analysis considering all five categories of number of pre-referral consultations available
Question
Number of
pre-referral visits Odds ratio†
95% confidence
interval P*
Evaluation
questions
Practice staff support 1 1.00 – <0.001
2 1.17 1.10–1.24
3–4 1.61 1.51–1.71
5+ 2.14 1.98–2.32
Cancer care integration 1 1.00 – <0.001
2 1.11 1.05–1.17
3–4 1.42 1.34–1.50
5+ 1.78 1.65–1.92
Overall care satisfaction 1 1.00 – <0.001
2 1.02 0.94–1.10
3–4 1.30 1.20–1.42
5+ 1.73 1.56–1.91
Told diagnosis sensitively 1 1.00 – <0.001
2 1.10 1.03–1.17
3–4 1.35 1.26–1.44
5+ 1.58 1.45–1.71
Thought information withheld 1 1.00 – <0.001
2 1.09 1.00–1.19
3–4 1.17 1.07–1.29
5+ 1.55 1.39–1.73
Confidence and trust – nurse 1 1.00 – <0.001
2 1.00 0.94–1.06
3–4 1.17 1.09–1.25
5+ 1.32 1.21–1.44
Confidence and trust – doctor 1 1.00 – <0.001
2 1.12 1.03–1.21
3–4 1.20 1.09–1.31
5+ 1.38 1.24–1.54
Shared decision-making 1 1.00 – <0.001
2 1.10 1.05–1.17
3–4 1.17 1.10–1.24
5+ 1.18 1.09–1.27
Report questions Information given to GP 1 1.00 – <0.001
2 1.17 1.05–1.31
3–4 1.28 1.14–1.45
5+ 1.73 1.51–1.99
Outpatient waiting time 1 1.00 0.020
2 1.03 0.96–1.11
3–4 1.08 0.99–1.17
5+ 1.17 1.05–1.30
Written info post-discharge 1 1.00 – 0.123
2 1.06 0.98–1.14
3–4 1.06 0.97–1.15
5+ 1.12 1.01–1.24
APPENDIX 3 . Continued
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Table . Continued
Question
Number of
pre-referral visits Odds ratio†
95% confidence
interval P*
Given name of CNS 1 1.00 – 0.133
2 1.04 0.96–1.12
3–4 0.96 0.88–1.05
5+ 1.10 0.99–1.22
Odds ratio values relate to negative experience outcomes. Questions are ordered as in Table 2 (main text).
*From joint tests for the categories ‘twice’, ‘three or four times’ and ‘five or more times’.
†Adjusted for age group, sex, ethnicity, cancer diagnosis and measure of response tendency.
APPENDIX 5
Sensitivity analysis using an alternative approach to measuring response tendency (using response to question 70 –
overall satisfaction with cancer care)
Question (number
and synoptic form) N
Odds ratios adjusted for
patient case-mix (age, sex,
ethnicity and cancer
diagnosis) ratios*
Odds ratios adjusted for
patient case-mix and
response to Question 70 (as
an alternative measure of
response tendency)
Odds ratios adjusted for
patient case-mix and
measure of response
tendency*
Odds
ratio 95% CI P
Odds
ratio 95% CI P
Odds
ratio 95% CI P
Evaluation items
Q64 Practice staff support 49 158 1.84 1.75–1.93 <0.001 1.72 1.64–1.81 <0.001 1.68 1.60–1.77 <0.001
Q65 Cancer care integration 70 003 1.67 1.60–1.74 <0.001 1.53 1.46–1.61 <0.001 1.48 1.41–1.55 <0.001
Q70 Overall care satisfaction 73 452 1.77 1.67–1.88 <0.001 n/a 1.44 1.35–1.54 <0.001
Q12 Told diagnosis sensitively 72 621 1.53 1.46–1.62 <0.001 1.40 1.33–1.48 <0.001 1.38 1.31–1.46 <0.001
Q45 Thought
information withheld
55 294 1.53 1.42–1.63 <0.001 1.33 1.23–1.43 <0.001 1.27 1.18–1.37 <0.001
Q42 Confidence and
trust – ward nurse
55 229 1.40 1.33–1.47 <0.001 1.26 1.20–1.33 <0.001 1.22 1.15–1.29 <0.001
Q38 Confidence and
trust – hospital doctor
55 494 1.52 1.42–1.62 <0.001 1.29 1.20–1.38 <0.001 1.22 1.13–1.31 <0.001
Q20 Shared decision-making 70 269 1.32 1.26–1.38 <0.001 1.17 1.12–1.23 <0.001 1.13 1.08–1.19 <0.001
Report items
Q63 Information given to GP 59 073 1.64 1.50–1.79 <0.001 1.41 1.28–1.55 <0.001 1.36 1.24–1.50 <0.001
Q61 Outpatient waiting time 32 999 1.17 1.10–1.25 <0.001 1.11 1.04–1.19 0.002 1.10 1.03–1.17 0.007
Q53 Written info
post-discharge
52 355 1.27 1.20–1.36 <0.001 1.13 1.06–1.21 <0.001 1.06 0.99–1.13 0.100
Q21 Given name of Clinical
Nurse Specialist (CNS)
69 793 1.10 1.03–1.18 0.006 1.02 0.95–1.10 0.556 1.00 0.93–1.07 0.894
Odds ratios (and related 95% confidence intervals and p-values) for negative experience between patients with ‘three or
more consultations’ with a general practitioner compared with ‘one or two consultations’ (used as the reference category).
Questions are ordered by effect size for response tendency model within evaluation and report categories.
*Reproduced from Table 2 – presented here for ease of comparisons.
APPENDIX 4 . Continued
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